# Treatment With Nab-paclitaxel in Cutaneous SCC

> **NCT02076243** · PHASE2 · TERMINATED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 2 (actual)

## Conditions studied

- Cutaneous Squamous Cell Carcinoma

## Interventions

- **DRUG:** nab-paclitaxel

## Key facts

- **NCT ID:** NCT02076243
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-03
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Closed by sponsor
- **Last updated:** 2017-10-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02076243

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02076243, "Treatment With Nab-paclitaxel in Cutaneous SCC". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02076243. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*